A murine model of FGFR2 fusion driven intrahepatic cholangiocarcinoma to delineate mechanism of therapeutic response and resistance to FGFR inhibitors

Kendre, G; Marhenke, S; Lorz, G; Saborowski, M; Vogel, A; Saborowski, A

JOURNAL OF HEPATOLOGY, 2021; 75 (): S249